Change
Release time:
2023-07-26
"Confucius said: 'It's not a pleasure to learn while learning! '" "The path in front of us needs to be open so that people can come and go." At 5: 30 every morning, the morning reading of our Jinhua Chinese sage culture class starts online. I have participated in the study class for more than two years. The study of Chinese sage culture has given me more confidence, calmness and calmness, and a new understanding of my life.
I remember that at the end of June of the lunar calendar in 2006, my mother was hospitalized with cerebral hemorrhage. She could not take care of herself. She had to be helped to wash her body and defecate. At that time, I felt that I could not do these things by myself, so my sister would do more. I would go to other errands. In the end, my mother died after staying in the intensive care unit of the hospital for more than ten days. Although there was a regret that "the child wanted to support but the parents did not wait", I still didn't realize what was wrong with me. After another year, my father was hospitalized with a cerebral hemorrhage. Although I was worried, I still took care of him as usual. The sick father also felt my thoughts and waited for his sister to scrub him every time. Until my father was discharged from hospital, I only knew how to buy all kinds of food for him.
2019 In October, I came into contact with the traditional Chinese sage culture and often had some insights. When I read that "if a filial son has deep love, he must have harmony, if he has harmony, if he has pleasure, if he has pleasure, if he has pleasure, he must have graceful tolerance, and if he has deep love as his root, he will naturally do so", suddenly my heart burst into tears. I asked myself, this is my filial piety? This filial piety exists in how many false ah? I this is in the body of adoptive parents, not adoptive parents heart ah!
Since then, my heart has untied a knot, and all the changes that follow are so natural. At ordinary times, my father has an aunt to take care of him. I come home on weekends, wipe his body, carry excrement and urinate. Everything is so natural and happy.
I remember washing my father's feet for the first time. I found that he was also an ordinary person, and the sole of his feet was even ticklish. Looking at his baby-like smile, he happily said in a vague way: "tap, itch, tap." Looking at his wrinkled and calloused feet, the fingernails of his thumbs were too hard to trim properly, and suddenly I thought that he and his mother, who had lost their parents at a young age, had worked hard to raise our five sisters. Such deep and heavy fatherly love was ignored by me in so many days. It was really...
I was glad that I had the opportunity to learn sage culture. It washed my heart and made me realize in time that I still have the opportunity to be filial to my father. The debt to my mother can be made up by my father, so I didn't leave more regrets! (Dai Xiaoping)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page